Starling Oncology, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Starling Oncology, Inc. (DFPH) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 3.25 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.25M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.14M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.04M shares.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.37M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2026-06-30 | 3.25M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 3.14M shares 10-Q · filed 2026-05-07 |
| 2025-09-30 | 3.04M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 3.37M shares 10-Q · filed 2026-08-06 |
| 2025-03-31 | 5.61M shares 10-Q · filed 2026-05-07 |
| 2024-09-30 | 5.41M shares 10-Q · filed 2025-11-13 |
| 2023-09-30 | 3.92M shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 3.64M shares 10-Q · filed 2023-08-09 |
| 2022-09-30 | 2.76M shares 10-Q · filed 2023-11-08 |
| 2022-06-30 | 2.42M shares 10-Q · filed 2023-08-09 |